Clinical Practice Guidelines for Clostridium difficile Infection in Adults and Children: 2017 Update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA)

TLDR

Clostridium difficile is the leading cause of healthcare‑associated diarrhea and infection in the United States, remains a common community pathogen, and the epidemic ribotype 027 continues to be a major strain in U.S. healthcare settings. The guideline aims to update the 2010 recommendations for Clostridium difficile infection by incorporating pediatric considerations and revising epidemiology, diagnosis, treatment, prevention, and environmental management. An expert panel from IDSA and SHEA convened to revise the guideline, adding child‑specific recommendations that follow adult standards and addressing evolving diagnostic controversies.

Abstract

Abstract A panel of experts was convened by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA) to update the 2010 clinical practice guideline on Clostridium difficile infection (CDI) in adults. The update, which has incorporated recommendations for children (following the adult recommendations for epidemiology, diagnosis, and treatment), includes significant changes in the management of this infection and reflects the evolving controversy over best methods for diagnosis. Clostridium difficile remains the most important cause of healthcare-associated diarrhea and has become the most commonly identified cause of healthcare-associated infection in adults in the United States. Moreover, C. difficile has established itself as an important community pathogen. Although the prevalence of the epidemic and virulent ribotype 027 strain has declined markedly along with overall CDI rates in parts of Europe, it remains one of the most commonly identified strains in the United States where it causes a sizable minority of CDIs, especially healthcare-associated CDIs. This guideline updates recommendations regarding epidemiology, diagnosis, treatment, infection prevention, and environmental management.